{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:49:38Z","timestamp":1778809778726,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T00:00:00Z","timestamp":1420848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s13760-014-0422-8","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T06:43:25Z","timestamp":1420785805000},"page":"657-663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["ADHD, autism and neuroradiological complications among phenylketonuric children in Upper Egypt"],"prefix":"10.1007","volume":"115","author":[{"given":"Khaled","family":"Saad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"Elserogy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Abdel rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman Abdullah","family":"Al-Atram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail L.","family":"Mohamad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek T. H.","family":"ElMelegy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geir","family":"Bj\u00f8rklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira A.","family":"El-Houfy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,10]]},"reference":[{"key":"422_CR1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/bchm2.1934.227.1-4.169","volume":"227","author":"A F\u00f8lling","year":"1934","unstructured":"F\u00f8lling A (1934) \u00dcber Ausscheidung von Phenylbrenztraubens\u00e4ure im Harn als Stoffwechselanomalie in Verbindung mit Imbezillit\u00e4t. Hoppe Seylers Z Physiol Chem. 227:169\u2013176","journal-title":"Hoppe Seylers Z Physiol Chem."},{"key":"422_CR2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000312813","volume":"68","author":"EL MacLeod","year":"2010","unstructured":"MacLeod EL, Ney DM (2010) Nutritional management of phenylketonuria. Ann Nestl\u00e9 (Engl). 68:58\u201369","journal-title":"Ann Nestl\u00e9 (Engl)."},{"key":"422_CR3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau N, van Spronsen FJ, Levy HL (2010) Phenylketonuria. Lancet 376:1417\u20131427","journal-title":"Lancet"},{"issue":"Suppl 1","key":"422_CR4","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.ymgme.2009.10.182","volume":"99","author":"VL Brumm","year":"2010","unstructured":"Brumm VL, Bilder D, Waisbren SE (2010) Psychiatric symptoms and disorders in phenylketonuria. Mol Genet Metab 99(Suppl 1):S59\u2013S63","journal-title":"Mol Genet Metab"},{"key":"422_CR5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1023\/B:BOLI.0000042985.02049.ff","volume":"27","author":"VL Brumm","year":"2004","unstructured":"Brumm VL, Azen C, Moats RA, Stern AM, Broomand C, Nelson MD, Koch R (2004) Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review. J Inherit Metab Dis 27:549\u2013566","journal-title":"J Inherit Metab Dis"},{"key":"422_CR6","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1007\/PL00014370","volume":"159","author":"R Surtees","year":"2000","unstructured":"Surtees R, Blau N (2000) The neurochemistry of phenylketonuria. Eur J Pediatr 159:S109\u2013S113","journal-title":"Eur J Pediatr"},{"key":"422_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11547-009-0365-y","volume":"114","author":"T Scarabino","year":"2009","unstructured":"Scarabino T, Popolizio T, Tosetti M, Montanaro D, Giannatempo GM, Terlizzi R, Pollice S, Maiorana A, Maggialetti N, Carriero A, Leuzzi V, Salvolini U (2009) Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion. Radiol Med. 114:461\u2013474","journal-title":"Radiol Med."},{"key":"422_CR8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jnnp.59.3.260","volume":"59","author":"SJ Jones","year":"1995","unstructured":"Jones SJ, Turano G, Kriss A, Shawkat F, Kendall B, Thompson AJ (1995) Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ. J Neurol Neurosurg Psychiatry 59:260\u2013265","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"422_CR9","first-page":"1667","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"CR Scriver","year":"2001","unstructured":"Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill, New York, pp 1667\u20131724","edition":"8"},{"key":"422_CR10","first-page":"31","volume":"29","author":"RA Williams","year":"2008","unstructured":"Williams RA, Mamotte CD, Burnett JR (2008) Phenylketonuria: an inborn error of metabolism. Clin Biochem Rev 29:31\u201340","journal-title":"Clin Biochem Rev"},{"key":"422_CR11","unstructured":"Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators; Centers for Disease Control and Prevention (2012) Prevalence of autism spectrum disorders\u2013Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ. 61(3):1\u201319"},{"key":"422_CR12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jama.297.9.940","volume":"297","author":"BM Kuehn","year":"2007","unstructured":"Kuehn BM (2007) CDC: autism spectrum disorders common. JAMA 297:940","journal-title":"JAMA"},{"key":"422_CR13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/0883073807308698","volume":"23","author":"B Manzi","year":"2008","unstructured":"Manzi B, Loizzo AL, Giana G, Curatolo P (2008) Autism and metabolic diseases. J Child Neurol 23:307\u2013314","journal-title":"J Child Neurol"},{"key":"422_CR14","doi-asserted-by":"crossref","unstructured":"Saad K, Hammad E, Abdel-rahman AA, Sobhy KM (2013) Autistic symptoms in late diagnosed phenylketonuric children in Upper Egypt. J Neur Res 3(3\u20134):122\u2013129","DOI":"10.4021\/jnr221w"},{"key":"422_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1192\/bjp.155.2.251","volume":"155","author":"CH Chen","year":"1989","unstructured":"Chen CH, Hsiao KJ (1989) A Chinese classic phenylketonuria manifested as autism. Br J Psych 155:251\u2013253","journal-title":"Br J Psych"},{"issue":"2A","key":"422_CR16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1590\/S0004-282X2007000200003","volume":"65","author":"CE Steiner","year":"2007","unstructured":"Steiner CE, Acosta AX, Guerreiro MM, Marques-de-Faria AP (2007) Genotype and natural history in unrelated individuals with phenylketonuria and autistic behavior. Arq Neuropsiquiatr 65(2A):202\u2013205","journal-title":"Arq Neuropsiquiatr"},{"key":"422_CR17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2788.2009.01197.x","volume":"53","author":"J Moss","year":"2009","unstructured":"Moss J, Howlin P (2009) Autism spectrum disorders in genetic syndromes: implications for diagnosis, intervention and understanding the wider autism spectrum disorder population. J Intel Dis Res. 53:852\u2013873","journal-title":"J Intel Dis Res."},{"key":"422_CR18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1469-8749.2009.03523.x","volume":"52","author":"AO Caglayan","year":"2010","unstructured":"Caglayan AO (2010) Genetic causes of syndromic and non-syndromic autism. Dev Med Child Neurol 52:130\u2013138","journal-title":"Dev Med Child Neurol"},{"key":"422_CR19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1023\/A:1026239921561","volume":"31","author":"KM Antshel","year":"2003","unstructured":"Antshel KM, Waisbren SE (2003) Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression. J Abnorm Child Psychol 31:565\u2013574","journal-title":"J Abnorm Child Psychol"},{"issue":"S1","key":"422_CR20","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.ymgme.2009.09.013","volume":"99","author":"KM Antshel","year":"2010","unstructured":"Antshel KM (2010) ADHD, learning, and academic performance in phenylketonuria. Mol Genet Metab 99(S1):S52\u2013S58","journal-title":"Mol Genet Metab"},{"key":"422_CR21","volume-title":"The Stanford Binet Intelligence Scale. Arabic Examiner\u2019s Handbook","author":"LK Melika","year":"1998","unstructured":"Melika LK (1998) The Stanford Binet Intelligence Scale. Arabic Examiner\u2019s Handbook, 4th edn. Dar El-Maref Publishing, Cairo","edition":"4"},{"key":"422_CR22","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-IV-TR","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association, Washington, DC"},{"key":"422_CR23","volume-title":"The Childhood Autism Rating Scale CARS","author":"E Schopler","year":"1994","unstructured":"Schopler E, Reichller R, Renner BR (1994) The Childhood Autism Rating Scale CARS. Western Psychological Services, Los Angeles"},{"key":"422_CR24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10803-004-5290-2","volume":"34","author":"E Rellini","year":"2004","unstructured":"Rellini E, Tortolani D, Trillo S, Carbone S, Montecchi F (2004) Childhood Autism Rating Scale CARS, and Autism Behavior Checklist ABC, correspondence and conflicts with DSM-IV criteria in diagnosis of autism. J Autism Dev Disord 34:703\u2013708","journal-title":"J Autism Dev Disord"},{"key":"422_CR25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10803-005-0006-9","volume":"355","author":"A Perry","year":"2005","unstructured":"Perry A, Condillac RA, Freeman NL, Dunn-Geier J, Belair J (2005) Multi-site study of the Childhood Autism Rating Scale (CARS) in five clinical groups of young children. J Autism Dev Disord 355:625\u2013634","journal-title":"J Autism Dev Disord"},{"key":"422_CR26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s004310050945","volume":"157","author":"J Pietz","year":"1998","unstructured":"Pietz J, Dunckelmann R, Rupp A, Rating D, Meinck HM, Schmidt H, Bremer HJ (1998) Neurological outcome in adult patients with early-treated phenylketonuria. Eur J Pediatr 157:824\u2013830","journal-title":"Eur J Pediatr"},{"key":"422_CR27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neubiorev.2008.11.001","volume":"33","author":"J Albrecht","year":"2009","unstructured":"Albrecht J, Garbade SF, Burgard P (2009) Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis. Neurosci Biobehav Rev 33:414\u2013421","journal-title":"Neurosci Biobehav Rev"},{"key":"422_CR28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000312815","volume":"68","author":"LH Crossley","year":"2010","unstructured":"Crossley LH, Anderson PJ (2010) Neuropsychological functioning in early-treated phenylketonuria\u2014a review. Ann Nestl\u00e9 (Engl). 68:78\u201388","journal-title":"Ann Nestl\u00e9 (Engl)."},{"key":"422_CR29","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-0361-6","volume-title":"Epilepsy: animal and human correlations","author":"DW McCandless","year":"2012","unstructured":"McCandless DW (2012) Epilepsy: animal and human correlations. Springer, New York"},{"key":"422_CR30","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez MJ, Guti\u00e9rrez AP, Gassi\u00f3 R, Fust\u00e9 ME, Vilaseca MA, Campistol J (2011) Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit. Mol Genet Metab 104:S73\u2013S79","DOI":"10.1016\/j.ymgme.2011.07.015"},{"key":"422_CR31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/08830738060210111401","volume":"21","author":"K Yalaz","year":"2006","unstructured":"Yalaz K, Vanli L, Yilmaz E, Tokatli A, Anlar B (2006) Phenylketonuria in pediatric neurology practice: a series of 146 cases. J Child Neurol 21:987\u2013990","journal-title":"J Child Neurol"},{"key":"422_CR32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/brain\/116.4.811","volume":"116","author":"AJ Thompson","year":"1993","unstructured":"Thompson AJ, Tillotson AJ, Smith I et al (1993) Brain MRI changes in phenylketonuria; associations with dietary status. Brain. 116:811\u2013821","journal-title":"Brain."},{"key":"422_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(94)91281-5","volume":"344","author":"MA Cleary","year":"1994","unstructured":"Cleary MA, Walter JH, Wraith JE, Jenkins JP, Alani SM, Tyler K, Whittle D (1994) Magnetic resonance imaging of the brain in phenylketonuria. Lancet 344:87\u201390","journal-title":"Lancet"},{"key":"422_CR34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF00711594","volume":"17","author":"PB Toft","year":"1994","unstructured":"Toft PB, Lou HC, Kr\u00e4geloh-Mann I, Andresen J, G\u00fcttler F, Guldberg P, Henriksen O (1994) Brain magnetic resonance imaging in children with optimally controlled hyperphenylalaninaemia. J Inherit Metab Dis 17:575\u2013583","journal-title":"J Inherit Metab Dis"},{"key":"422_CR35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1651-2227.1995.tb13661.x","volume":"84","author":"J Weglage","year":"1995","unstructured":"Weglage J, Pietsch M, F\u00fcnders B, Koch HG, Ullrich K (1995) Neurological findings in early treated phenylketonuria. Acta Paediatr 84:411\u2013415","journal-title":"Acta Paediatr"},{"key":"422_CR36","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.jcbfm.9600571","volume":"28","author":"C Landvogt","year":"2008","unstructured":"Landvogt C, Mengel E, Bartenstein P, Buchholz HG, Schreckenberger M, Siessmeier T, Scheurich A, Feldmann R, Weglage J, Cumming P, Zepp F, Ullrich K (2008) Reduced cerebral fluoro-l-dopamine uptake in adult patients suffering from phenylketonuria. J Cereb Blood Flow Metab 28:824\u2013831","journal-title":"J Cereb Blood Flow Metab"},{"key":"422_CR37","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1054-3589(08)60846-7","volume":"42","author":"PS Goldman-Rakic","year":"1998","unstructured":"Goldman-Rakic PS (1998) The cortical dopamine system: role in memory and cognition. Adv Pharmacol 42:707\u2013711","journal-title":"Adv Pharmacol"},{"issue":"2","key":"422_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:BOLI.0000028725.37345.62","volume":"27","author":"GL Arnold","year":"2004","unstructured":"Arnold GL, Vladutiu CJ, Orlowski CC, Blakely EM, DeLuca J (2004) Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria. J Inherit Metab Dis 27(2):137\u2013143","journal-title":"J Inherit Metab Dis"},{"key":"422_CR39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1176\/jnp.2009.21.2.228","volume":"21","author":"J Posner","year":"2009","unstructured":"Posner J, Gorman D, Nagel BJ (2009) Tyrosine supplements for ADHD symptoms with comorbid phenylketonuria. J Neuropsychiatry Clin Neurosci 21:228\u2013230","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"422_CR40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1022999712639","volume":"33","author":"S Baieli","year":"2003","unstructured":"Baieli S, Pavone L, Meli C, Fiumara A, Coleman M (2003) Autism and phenylketonuria. J Autism Dev Disord 33:201\u2013204","journal-title":"J Autism Dev Disord"},{"key":"422_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.braindev.2006.09.003","volume":"29","author":"DI Zafeiriou","year":"2007","unstructured":"Zafeiriou DI, Ververi A, Vargiami E (2007) Childhood autism and associated comorbidities. Brain Dev 29:257\u2013272","journal-title":"Brain Dev"},{"key":"422_CR42","first-page":"351","volume":"74","author":"N Okado","year":"1999","unstructured":"Okado N (1999) Mechanisms for formation and maintenance of synapses mediated by biogenic amines: pathogenesis and therapy of mental retardation and developmental disabilities by genetic and epigenetic factors. Kaibogaku Zasshi. 74:351\u2013362","journal-title":"Kaibogaku Zasshi."},{"key":"422_CR43","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1469-8749.2004.tb00477.x","volume":"46","author":"PJ Anderson","year":"2004","unstructured":"Anderson PJ, Wood SJ, Francis DE, Coleman L, Warwick L, Casanelia S, Anderson VA, Boneh A (2004) Neuropsychological functioning in children with early-treated phenylketonuria: impact of white matter abnormalities. Dev Med Child Neurol 46:230\u2013238","journal-title":"Dev Med Child Neurol"},{"key":"422_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymgme.2009.10.005","volume":"99","author":"PJ Anderson","year":"2010","unstructured":"Anderson PJ, Leuzzi V (2010) White matter pathology in phenylketonuria. Mol Genet Metab 99:3\u20139","journal-title":"Mol Genet Metab"},{"key":"422_CR45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1207\/s15326942dn3003_5","volume":"30","author":"SE Christ","year":"2006","unstructured":"Christ SE, Steiner RD, Grange DK, Abrams RA, White DA (2006) Inhibitory control in children with phenylketonuria. Dev Neuropsychol. 30:845\u2013864","journal-title":"Dev Neuropsychol."},{"issue":"2","key":"422_CR46","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/87565640701375963","volume":"32","author":"PJ Anderson","year":"2007","unstructured":"Anderson PJ, Wood SJ, Francis DE, Coleman L, Anderson V, Boneh A (2007) Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels? Dev Neuropsychol. 32(2):645\u2013668","journal-title":"Dev Neuropsychol."}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-014-0422-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-014-0422-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-014-0422-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T12:56:36Z","timestamp":1559480196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-014-0422-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,10]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1007\/s13760-014-0422-8","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,10]]}}}